ECOFIBRE LIMITED (EOF)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

EOF - ECOFIBRE LIMITED

Year End: June
GICS Industry Group : Pharmaceuticals, Biotechnology & Life Sciences
Debt/EBITDA: 0.86
Index:

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.20

26 May
2023

0.005

OPEN

$0.20

2.56%

HIGH

$0.21

114,574

LOW

$0.20

OTHER COMPANIES IN THE SAME SECTOR
1AD . ACR . ACW . ADO . AFP . AGH . AHZ . ANP . ARX . AVH . BIO . BNO . BOT . CAU . CSL . CUV . FTT . GSS . HXL . IDT . IMM . IMU . IVX . KZA . LGP . MAP . MDC . MSB . MVP . MXC . MYX . NEU . NXS . OCC . OPT . OSL . PAL . PAR . PBP . PNV . PXS . PYC . RAC . RCE . RNO . SPL . TFC . TIS . TLX . TRP . ZNO .
FNARENA'S MARKET CONSENSUS FORECASTS

- No Record -

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2023 FactSet UK Limited. All rights reserved
Title 201720182019202020212022
EPS Basic xxxxxxxxxxxxxxx-4.4
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx30.2 M
Book Value Per Share xxxxxxxxxxxxxxx32.8
Net Operating Cash Flow xxxxxxxxxxxxxxx-10.6 M
Net Profit Margin xxxxxxxxxxxxxxx-48.54 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201720182019202020212022
Return on Capital Employed xxxxxxxxxxxxxxx-13.23 %
Return on Invested Capital xxxxxxxxxxxxxxx-11.76 %
Return on Assets xxxxxxxxxxxxxxx-10.07 %
Return on Equity xxxxxxxxxxxxxxx-13.23 %
Return on Total Capital xxxxxxxxxxxxxxx-17.65 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx-13.4 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201720182019202020212022
Short-Term Debt xxxxxxxxxxxxxxx2 M
Long Term Debt xxxxxxxxxxxxxxx17 M
Total Debt xxxxxxxxxxxxxxx20 M
Goodwill - Gross xxxxxxxxxxxxxxx51 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx7 M
Price To Book Value xxxxxxxxxxxxxxx0.61

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201720182019202020212022
Capex xxxxxxxxxxxxxxx2.8 M
Capex % of Sales xxxxxxxxxxxxxxx9.24 %
Cost of Goods Sold xxxxxxxxxxxxxxx36 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx16 M
Research & Development xxxxxxxxxxxxxxx6 M
Investments - Total xxxxxxxxxxxxxxx-

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

0
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

EOF STOCK CHART